TELA Bio (TELA) Gross Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.00 |
| Dec 31, 2025 | -161.00 |
| Sep 30, 2025 | -232.00 |
| Jun 30, 2025 | 228.00 |
| Mar 31, 2025 | 398.00 |
| Dec 31, 2024 | -425.00 |
| Sep 30, 2024 | -99.00 |
| Jun 30, 2024 | 54.00 |
| Mar 31, 2024 | -11.00 |
| Dec 31, 2023 | -64.00 |
| Sep 30, 2023 | -136.00 |
| Jun 30, 2023 | 406.00 |
| Mar 31, 2023 | -403.00 |
| Dec 31, 2022 | 476.00 |
| Sep 30, 2022 | 264.00 |
| Jun 30, 2022 | 221.00 |
| Mar 31, 2022 | -684.00 |
| Dec 31, 2021 | 745.00 |
| Sep 30, 2021 | -718.00 |
| Jun 30, 2021 | 835.00 |
| Mar 31, 2021 | -566.00 |
| Dec 31, 2020 | 275.00 |
| Sep 30, 2020 | 241.00 |
| Jun 30, 2020 | 41.00 |
| Mar 31, 2020 | -187.00 |
| Dec 31, 2019 | -463.00 |
| Sep 30, 2019 | 781.00 |
| Jun 30, 2019 | 335.00 |
| Mar 31, 2019 | 1,203.00 |
| Dec 31, 2018 | -1,944.00 |